Title : Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial.

Pub. Date : 2017 Oct 4

PMID : 28978327






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Especially upon treatment with the life-prolonging cytochrome P450 17-alpha-hydroxylase (Cyp17)-inhibitor, abiraterone, which has the ability to further suppress testosterone serum levels over LHRH therapy alone, continuation of LHRH therapy seems to be negligible. Testosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 Especially upon treatment with the life-prolonging cytochrome P450 17-alpha-hydroxylase (Cyp17)-inhibitor, abiraterone, which has the ability to further suppress testosterone serum levels over LHRH therapy alone, continuation of LHRH therapy seems to be negligible. Testosterone cytochrome P450 family 17 subfamily A member 1 Homo sapiens